MX9300204A - Composicion farmaceutica que contiene azauridina para el tratamiento de la artritis reumatoide. - Google Patents

Composicion farmaceutica que contiene azauridina para el tratamiento de la artritis reumatoide.

Info

Publication number
MX9300204A
MX9300204A MX9300204A MX9300204A MX9300204A MX 9300204 A MX9300204 A MX 9300204A MX 9300204 A MX9300204 A MX 9300204A MX 9300204 A MX9300204 A MX 9300204A MX 9300204 A MX9300204 A MX 9300204A
Authority
MX
Mexico
Prior art keywords
rheumatoid arthritis
azauridine
treatment
pharmaceutical composition
composition containing
Prior art date
Application number
MX9300204A
Other languages
English (en)
Inventor
William Drell
Original Assignee
Ur Labs Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ur Labs Inc filed Critical Ur Labs Inc
Publication of MX9300204A publication Critical patent/MX9300204A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Se describe un método para tratar pacientes con artritis reumatoide que comprende administrar azaribina al paciente a un nivel de dosificación de 10 a 50 mg/kg/día durante un período inicial desde aproximadamente 1 a aproximadamente 3 semanas y después administrar azaribina al paciente a niveles de dosificación de por lo menos 50 mg/kg/día y preferiblemente por lo menos 100 mg/kg/día.
MX9300204A 1992-01-17 1993-01-15 Composicion farmaceutica que contiene azauridina para el tratamiento de la artritis reumatoide. MX9300204A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US82263092A 1992-01-17 1992-01-17

Publications (1)

Publication Number Publication Date
MX9300204A true MX9300204A (es) 1994-07-29

Family

ID=25236558

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9300204A MX9300204A (es) 1992-01-17 1993-01-15 Composicion farmaceutica que contiene azauridina para el tratamiento de la artritis reumatoide.

Country Status (6)

Country Link
US (1) US5389617A (es)
EP (1) EP0552057A1 (es)
JP (1) JPH05345723A (es)
AU (1) AU661364B2 (es)
CA (1) CA2087147A1 (es)
MX (1) MX9300204A (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8828432B2 (en) 1996-10-28 2014-09-09 General Mills, Inc. Embedding and encapsulation of sensitive components into a matrix to obtain discrete controlled release particles
US7201923B1 (en) 1998-03-23 2007-04-10 General Mills, Inc. Encapsulation of sensitive liquid components into a matrix to obtain discrete shelf-stable particles
JP2002507399A (ja) 1998-03-23 2002-03-12 ゼネラル ミルズ インコーポレイテッド 可食性製品への成分のカプセル化
US6500463B1 (en) 1999-10-01 2002-12-31 General Mills, Inc. Encapsulation of sensitive components into a matrix to obtain discrete shelf-stable particles
US6468568B1 (en) 2000-06-16 2002-10-22 General Mills, Inc. Oligosaccharide encapsulated mineral and vitamin ingredients
US6436453B1 (en) 2000-06-16 2002-08-20 General Mills, Inc. Production of oil encapsulated minerals and vitamins in a glassy matrix
US6558718B1 (en) 2000-06-19 2003-05-06 General Mills, Inc. Nutrient clusters for food products and methods of preparation
US8563525B2 (en) 2004-01-12 2013-10-22 Natrogen Therapeutics International, Inc. Methods of treating an inflammatory-related disease
US7582670B2 (en) * 2001-12-13 2009-09-01 Natrogen Therapeutics, Inc. Methods of treating an inflammatory-related disease
US20050154046A1 (en) * 2004-01-12 2005-07-14 Longgui Wang Methods of treating an inflammatory-related disease
US7431986B2 (en) 2002-07-24 2008-10-07 General Mills, Inc. Encapsulation of sensitive components using pre-emulsification
US7803413B2 (en) 2005-10-31 2010-09-28 General Mills Ip Holdings Ii, Llc. Encapsulation of readily oxidizable components
CN101426268B (zh) * 2007-11-02 2010-08-25 大唐移动通信设备有限公司 导频资源分配方法、系统和设备

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1211375A (en) * 1982-04-22 1986-09-16 Slavik Milan Azauridine pyridoxine composition
US5023083A (en) * 1987-09-23 1991-06-11 William Drell Azarbine composition

Also Published As

Publication number Publication date
US5389617A (en) 1995-02-14
EP0552057A1 (en) 1993-07-21
AU661364B2 (en) 1995-07-20
CA2087147A1 (en) 1993-07-18
JPH05345723A (ja) 1993-12-27
AU3183293A (en) 1993-07-22

Similar Documents

Publication Publication Date Title
MX9300204A (es) Composicion farmaceutica que contiene azauridina para el tratamiento de la artritis reumatoide.
ES2179473T3 (es) Composiciones que contienen capsaicina o analogos de capsaicina y un anestesico local.
KR880012218A (ko) 캘폰 유도체를 사용한 다발성 경화증의 치료방법
ES2137948T3 (es) Sistema avanzado de administracion de medicamentos y metodo de tratamiento de trastornos psiquiatricos, neurologicos y otros con carbamacepina.
NO180677C (no) Anvendelse av (S)-(+)-hydroksyklorokin for fremstilling av legemidler
HUT77380A (hu) Kombinált gyógyszerkészítmény alkalmazása sclerosis multiplex (MS) és más demielizáló állapotok kezelésére
KR940018089A (ko) 내부조직의 방사선 손상에 대한 예방 및 처치방법
BR9916114A (pt) Uso de apomorfina na fabricação de um medicamento para tratamento de disfunção erétil orgânica masculina
KR950007848A (ko) (S)-(-)-α-에틸-2-옥소-1-피롤리딘아세트아미드를 사용한 불안치료방법
ATE229809T1 (de) Verwendung von magnesium enthaltenden verbindungen zur behandlung oder prophylaxe von krebs- und autoimmunkrankheiten
MA22915A1 (fr) Methodes de traitement de l'osteoporose pour utilisation de faibles doses de phosphonates.
DE69420776D1 (de) Idebenone-haltige Zusammensetzungen zur Behandlung von M. Alzheimer
ATE173926T1 (de) Arzneizusammensetzungen enthaltend tandospiron oder seine analoge
DE69131553D1 (de) Arzneimittel enthaltend Mischungen von höheren primären aliphatischen Alkoholen zur Behandlung von Hypercholesterolämie und Hyperlipoproteinämie Typ II und zur Stimulation des sexuellen Verhaltens bei Tieren und Menschen
KR890004705A (ko) 항바이러스성 제제
KR930003913A (ko) 덱스트로메토르판의 진해효과를 증진시키기 위한 방법 및 약제학적 조성물
KR890001558A (ko) 공황(恐慌) 장애를 경감시키는 제피론 및 이의 약학적 허용 산부가염
KR880009652A (ko) 3-5-디클로로메토트랙세이트를 사용하는 류마티스성 관절염 치료법 및 그에 유용한 조성물
KR890007737A (ko) 진토작용을 하는 약제
ATE122889T1 (de) Verwendung von mizoribin zur behandlung oder vorbeugung der multiplen sklerose.
Lichtigfeld Mixed anaerobic infection in minor trauma
KR890001567A (ko) 디플루니살 및 트로메타민-함유 조성물
IL103499A0 (en) Pharmaceutical compositions for treating anxiety in benzodiazepine withdrawn patients
UA10069A (uk) Спосіб профілактики та лікування гнойної раневої інфекції
RU93058154A (ru) Способ лечения ранних приобретенных форм сифилиса